A novel approach to improve detection of glucocorticoid doping in sport with new guidance for physicians prescribing for athletes. Issue 11 (20th April 2021)

• Record Type: Journal Article
• Authors: Ventura, Rosa; Daley-Yates, Peter; Mazzoni, Irene; Collomp, Katia; Saugy, Martial; Buttgereit, Frank; Rabin, Olivier; Stuart, Mark
• Is Part Of: British journal of sports medicine. Volume 55:Issue 11(2021)
• Page Start: 631
• Page End: 642
• Publication Date: 2021-04-20
• Subjects: doping -- corticosteroids -- sports physician -- sports and exercise medicine -- athlete; Sports medicine -- Periodicals; 617.1027
• DOI: 10.1136/bjsports-2020-103512
• Languages: English
• ISSNs: 0306-3674

Abstract

Abstract : The systemic effect of glucocorticoids (GCs) following injectable routes of administration presents a potential risk to both improving performance and causing harm to health in athletes. This review evaluates the current GC antidoping regulations defined by the World Anti-Doping Agency and presents a novel approach for defining permitted and prohibited use of glucocorticoids in sport based on the pharmacological potential for performance enhancement (PE) and risk of adverse effects on health. Known performance-enhancing doses of glucocorticoids are expressed in terms of cortisol-equivalent doses and thereby the dose associated with a high potential for PE for any GC and route of administration can be derived. Consequently, revised and substance-specific laboratory reporting values are presented to better distinguish between prohibited and permitted use in sport. In addition, washout periods are presented to enable clinicians to prescribe glucocorticoids safely and to avoid the risk of athletes testing positive for a doping test.